Skip to content
10-Q

Quarterly Report

Unicycive Therapeutics, Inc. UNCY

0001213900-25-108600

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 21.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 18.07M sh
Shares Diluted Q3 2025 · Sep 30, 2025 14.04M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 8.89M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 5.41M sh
Capex Q3 2025 · Sep 30, 2025 $24K
Capex Q3 2025 · Sep 30, 2024 $50K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$23.29M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$22.03M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $42.7M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $26.14M
Stockholders Equity Q3 2025 · Sep 30, 2025 $37.48M
Stockholders Equity Q3 2025 · Jun 30, 2025 $16.43M
Stockholders Equity Q3 2025 · Mar 31, 2025 $11.27M
Stockholders Equity Q3 2025 · Dec 31, 2024 $7.43M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$27.85M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$14.85M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$24.46M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$3.81M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.13M
Current Liabilities Q3 2025 · Dec 31, 2024 $24.12M
Total Liabilities Q3 2025 · Sep 30, 2025 $13.13M
Total Liabilities Q3 2025 · Dec 31, 2024 $24.24M
Current Assets Q3 2025 · Sep 30, 2025 $50.29M
Current Assets Q3 2025 · Dec 31, 2024 $30.95M
Total Assets Q3 2025 · Sep 30, 2025 $50.61M
Total Assets Q3 2025 · Dec 31, 2024 $31.67M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.85
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.46
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$3.01
Eps Basic Q3 2025 · Sep 30, 2025 −$0.33
Eps Basic Q3 2025 · Sep 30, 2025 −$0.85
Eps Basic restated Q3 2025 · Sep 30, 2024 −$0.46
Eps Basic restated Q3 2025 · Sep 30, 2024 −$3.01
Rd Expense Q3 2025 · Sep 30, 2025 $2.96M
Rd Expense Q3 2025 · Sep 30, 2025 $6.87M
Rd Expense Q3 2025 · Sep 30, 2024 $3.05M
Rd Expense Q3 2025 · Sep 30, 2024 $14.73M
Net Income Q3 2025 · Sep 30, 2025 −$6.01M
Net Income Q3 2025 · Sep 30, 2025 −$11.89M
Net Income Q3 2025 · Jun 30, 2025 −$6.45M
Net Income Q3 2025 · Mar 31, 2025 $570K
Net Income Q3 2025 · Sep 30, 2024 −$4.1M
Net Income Q3 2025 · Sep 30, 2024 −$15.2M
Net Income Q3 2025 · Jun 30, 2024 $9.86M
Net Income Q3 2025 · Mar 31, 2024 −$20.96M
Operating Income Q3 2025 · Sep 30, 2025 −$7.34M
Operating Income Q3 2025 · Sep 30, 2025 −$22.29M
Operating Income Q3 2025 · Sep 30, 2024 −$6.25M
Operating Income Q3 2025 · Sep 30, 2024 −$22.86M
Dividends Paid Q3 2025 · Sep 30, 2024 $1.1M